(Washington, DC) -- About four million doses of a third coronavirus vaccine could be headed to states next week.

That's if the FDA approves Johnson and Johnson's single-shot on Saturday.

The White House expected ten million doses to be ready, but the company is behind on production.  

The FDA says the vaccine offers strong protection, showing 86-percent effective against severe forms of COVID-19 in the U.S.